These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10593699)

  • 1. Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.
    Moore CM; Frederick BB; Renshaw PF
    J Geriatr Psychiatry Neurol; 1999; 12(3):107-17. PubMed ID: 10593699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment.
    Griffith HR; Stewart CC; den Hollander JA
    Int Rev Neurobiol; 2009; 84():105-31. PubMed ID: 19501715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 31P RINEPT MRSI and VBM reveal alterations in brain aging associated with major depression.
    Biedermann SV; Weber-Fahr W; Demirakca T; Tunc-Skarka N; Hoerst M; Henn F; Sartorius A; Ende G
    Magn Reson Med; 2015 Apr; 73(4):1390-400. PubMed ID: 24798730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of magnetic resonance spectroscopy in the study of brain disease].
    Pérez-Gómez M; Junqué C; Mercader JM; Berenguer J
    Rev Neurol; 2000 Jan 16-31; 30(2):155-60. PubMed ID: 10730323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy in psychiatry: basic principles and applications.
    Frangou S; Williams SC
    Br Med Bull; 1996 Jul; 52(3):474-85. PubMed ID: 8949251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance spectroscopy: current and future applications in psychiatric research.
    Lyoo IK; Renshaw PF
    Biol Psychiatry; 2002 Feb; 51(3):195-207. PubMed ID: 11839362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal brain aging and Alzheimer's disease are associated with lower cerebral pH: an in vivo histidine
    Lyros E; Ragoschke-Schumm A; Kostopoulos P; Sehr A; Backens M; Kalampokini S; Decker Y; Lesmeister M; Liu Y; Reith W; Fassbender K
    Neurobiol Aging; 2020 Mar; 87():60-69. PubMed ID: 31902521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy in psychiatry: potential, pitfalls, and promise.
    Keshavan MS; Kapur S; Pettegrew JW
    Am J Psychiatry; 1991 Aug; 148(8):976-85. PubMed ID: 1853987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroanatomic substrates of late-life mental disorders.
    Narayan M; Bremner JD; Kumar A
    J Geriatr Psychiatry Neurol; 1999; 12(3):95-106. PubMed ID: 10593698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
    J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of magnetic resonance spectroscopy to the investigation of neuropsychiatric disorders.
    Dager SR; Steen RG
    Neuropsychopharmacology; 1992 Jun; 6(4):249-66. PubMed ID: 1632893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging.
    Mato Abad V; Quirós A; García-Álvarez R; Loureiro JP; Alvarez-Linera J; Frank A; Hernández-Tamames JA
    J Alzheimers Dis; 2014; 42(3):801-11. PubMed ID: 24927708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade.
    Port JD
    Neuroimaging Clin N Am; 2020 Feb; 30(1):25-33. PubMed ID: 31759569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.
    Dager SR; Corrigan NM; Richards TL; Posse S
    Top Magn Reson Imaging; 2008 Apr; 19(2):81-96. PubMed ID: 19363431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
    Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
    Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance spectroscopy in neonatal hypoxic-ischaemic insults.
    Cady EB
    Childs Nerv Syst; 2001 Feb; 17(3):145-9. PubMed ID: 11305767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.
    Metastasio A; Rinaldi P; Tarducci R; Mariani E; Feliziani FT; Cherubini A; Pelliccioli GP; Gobbi G; Senin U; Mecocci P
    Neurobiol Aging; 2006 Jul; 27(7):926-32. PubMed ID: 15936850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.